Metabolic improvements typically emerge gradually over several months, with meaningful changes in glycemic control and insulin sensitivity markers generally observed within 1216 weeks and maximal effects by 6 months of treatment
Cold Chain Storage: Store your unused, unopened Obesema pens in the refrigerator between 2C to 8C
GLP-1 agonists are glucagon-like peptide-1 receptor agonists used for type 2 diabetes and weight management in the UK
They are not intended for human or animal consumption, clinical use, or veterinary applications, and are not intended to diagnose, treat, cure, or prevent any disease
This is not a reason to avoid higher doses if they are medically appropriate
The company now expects adjusted sales growth and adjusted operating profit growth to decline between 4% and 12% at constant exchange rates, compared with prior guidance calling for a potential 13% decline